Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AbbVie : Vice Chairman, Chief Commercial Officer Carlos Alban to Retire

11/12/2020 | 11:23am EST

By Colin Kellaher

AbbVie Inc. on Thursday said Carlos Alban plans to retire as vice chairman and chief commercial officer at the end of the first quarter 2021.

The North Chicago, Ill., biopharmaceutical company said Jeffrey Stewart, currently senior vice president of U.S. commercial operations, will succeed Mr. Alban as executive vice president of commercial operations.

Mr. Alban, who was named vice chairman in late 2018, previously served as executive vice president of commercial operations and served as served as senior vice president of proprietary pharmaceutical products, global commercial operations, prior to AbbVie's separation from Abbott Laboratories.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

11-12-20 1055ET

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 0.05% 112.95 Delayed Quote.3.11%
ABBVIE INC. -1.21% 111.26 Delayed Quote.5.11%
All news about ABBVIE INC.
01/18ABBVIE : Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neur..
AQ
01/15ABBVIE : Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neur..
PR
01/14ABBVIE INC. : Ex-dividend day for
FA
01/13SECTOR UPDATE : Health Care Stocks Rise in Cautious Wednesday Trade
MT
01/13SECTOR UPDATE : Health Care Stocks Maintaining Moderate Advance
MT
01/13GENMAB A/S : to Receive $40 Million Milestone Payment From AbbVie
MT
01/13HARPOON THERAPEUTICS : FDA Grants Orphan Drug Status to Harpoon Therapeutics, Ab..
MT
01/12ABBVIE : J.P. Morgan Healthcare Conference Presentation 985.1 KB
PU
01/12ABBVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
01/12ABBVIE : Unit Allergan Enters Into Option to Buy Cypris Medical
MT
More news
Financials (USD)
Sales 2020 45 636 M - -
Net income 2020 12 355 M - -
Net Debt 2020 75 457 M - -
P/E ratio 2020 27,2x
Yield 2020 4,28%
Capitalization 196 B 196 B -
EV / Sales 2020 5,96x
EV / Sales 2021 4,81x
Nbr of Employees 47 000
Free-Float 98,5%
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | ABBV | US00287Y1091 | MarketScreener
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 115,91 $
Last Close Price 111,26 $
Spread / Highest target 21,3%
Spread / Average Target 4,18%
Spread / Lowest Target -12,8%
EPS Revisions
Managers and Directors
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.5.11%198 828
JOHNSON & JOHNSON3.18%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.84%202 881